Profile
Finovam is a venture capital firm based in Villeneuve d’Ascq, France. It was established on June 19, 2015, and is focused on investing in future technological leaders. With a dedicated team, the firm prides itself on its proximity and expertise, concentrating on being deeply involved in the industries they invest in. Finovam's approach includes supporting innovative companies in various sectors with the aim of leading technological advancements.
Finovam invests across sectors including IT, bio-economy, health and biotechnologies, and industries of the future. The firm's typical investment stages range from seed to Series A, with check sizes inferred to be between $0-1 m to $1-5 m. The firm focuses primarily within Europe and has developed extensive networks to support the scaling of its portfolio companies.
Some notable investments include AlzProtect, which develops molecules for treating neurodegenerative diseases, OVERSOC, providing cybersecurity infrastructure solutions, and Tiamat, which creates sodium-ion battery technologies for rapid charging and power provision. These companies underline Finovam's commitment to fostering breakthrough innovations in its chosen sectors.
Industry
Finovam Funds
| Name | Type |
|
|
|
Size | AUM | Launch date |
|---|---|---|---|---|---|---|---|
|
Finovam Gestion Fund
|
Venture Capital (VC)
|
Healthcare Services
Energy
CleanTech
Cybersecurity
Internet of Things (IoT)
|
Seed
Series A
Series B
|
Europe
|
$5-10 m
|
$109 M
|
December 2015
|
Contacts
Instant access on the web. Plans from $129/month — see pricing.